Publications
- Evaluation of multiple sclerosis treatment efficacy in 21st century2019 | First Faculty of Medicine
- Ocrelizumab in the treatment of multiple sclerosis - view of a neurologist and immunologist2018 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Vitamin D and multiple sclerosis2017 | First Faculty of Medicine
- Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later2016 | First Faculty of Medicine
- Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party2015 | First Faculty of Medicine
- Treatment intramuscular interferon beta-1a2013 | First Faculty of Medicine
- Multiple sclerosis treatment -today and trends for the future2011 | First Faculty of Medicine
- Natalizumab in the treatment of multiple sclerosis2011 | First Faculty of Medicine
- High-dose immunoablation with autologous haematopoietic stem cell transplantation in aggressive multiple sclerosis: a single centre 10-year experience2010 | First Faculty of Medicine, Third Faculty of Medicine
- Contemporary treatment of relapsing-remitting multiple sclerosis and future perspectives2008 | First Faculty of Medicine
Loading network view...